Surmodics Inc
NASDAQ:SRDX

Watchlist Manager
Surmodics Inc Logo
Surmodics Inc
NASDAQ:SRDX
Watchlist
Price: 29.46 USD 0.2% Market Closed
Market Cap: 421m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

SRDX Price Targets Summary
Surmodics Inc

Wall Street analysts forecast SRDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRDX is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

SRDX Lowest Forecast
Wall Street Target
43.43 USD
47% Upside
SRDX Average Forecast
Wall Street Target
43.86 USD
49% Upside
SRDX Highest Forecast
Wall Street Target
45.15 USD
53% Upside
Lowest
Price Target
43.43 USD
47% Upside
Average
Price Target
43.86 USD
49% Upside
Highest
Price Target
45.15 USD
53% Upside
Surmodics Inc Competitors:
Price Targets
BDX
Becton Dickinson and Co
34% Upside
ELN
El En SpA
41% Upside
SOM
Somnomed Ltd
94% Upside
EMBLA
Embla Medical hf
25% Upside
BDX
Becton Dickinson and Co
34% Upside
ELN
El En SpA
41% Upside
SOM
Somnomed Ltd
94% Upside
EMBLA
Embla Medical hf
25% Upside
BSX
Boston Scientific Corp
16% Upside
ZBH
Zimmer Biomet Holdings Inc
22% Upside
TMDX
Transmedics Group Inc
26% Upside
300633
SonoScape Medical Corp
36% Upside

Revenue
Forecast

Revenue Estimate
Surmodics Inc

For the last 8 years the compound annual growth rate for Surmodics Inc's revenue is 7%. The projected CAGR for the next 3 years is 3%.

7%
Past Growth
3%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Surmodics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Surmodics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
What are analyst estimates?

See Also

Summary
SRDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
SRDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SRDX stock valuation using valuation multiples.
Wall Street Estimates
SRDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SRDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRDX's stock price target?
Price Target
43.86 USD

According to Wall Street analysts, the average 1-year price target for SRDX is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

What is Surmodics Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Surmodics Inc's revenue is 7%. The projected CAGR for the next 3 years is 3%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.